🇺🇸 FDA
Patent

US 8975300

Ketone compounds and compositions for cholesterol management and related uses

granted A61PA61P1/00A61P1/16

Quick answer

US patent 8975300 (Ketone compounds and compositions for cholesterol management and related uses) held by Esperion Therapeutics, Inc. expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Esperion Therapeutics, Inc.
Grant date
Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P1/00, A61P1/16, A61P1/18, A61P13/12